# Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype

> **NCT04901715** · EARLY_PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 27 (actual)

## Conditions studied

- Primary Ciliary Dyskinesia

## Interventions

- **DRUG:** Albuterol
- **DIAGNOSTIC_TEST:** Technetium99m - Sulfur Colloid (Tc99m-SC)

## Key facts

- **NCT ID:** NCT04901715
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-10
- **Primary completion:** 2024-07-22
- **Final completion:** 2024-07-22
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04901715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04901715, "Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04901715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*